1,972
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial

, , , , , , , , & show all
Pages 3109-3118 | Received 09 Feb 2021, Accepted 29 Jun 2021, Published online: 26 Jul 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.